Chronos Archive seal

Review checklist: Zora Neale Hurston (HR-ML040)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check treating stage 2 blood pressure the morning after a 24-hour ambulatory recording, chlorthalidone with amlodipine as the initial combination, the HFpEF diagnosis (NT-proBNP 480, ejection fraction 62%, E/e' 15, left atrial volume index 38), dapagliflozin, spironolactone for low potassium and blood pressure above target, the missed one- to two-week potassium check, the orthostatic episode in the heat, and moderate-intensity atorvastatin.
provenance reviewnot_startedSources: PBS American Masters, the Zora Neale Hurston Trust (Valerie Boyd's essay and chronology), the University of Florida Smathers Libraries, the Encyclopedia of Alabama, the Florida Department of State and a Library of Congress research guide. The Library of Congress collection pages, Florida Memory, the Smithsonian NMAAHC and the New York Times could not be fetched; Robert Hemenway's and Valerie Boyd's biographies were not read directly.
safe messaging reviewnot_startedPoverty, the welfare home and the unmarked grave are recorded plainly as history, without pity or graphic detail. No mental health claim is made; mood screening is synthetic and negative. No relative or other real person is given a modern statement, decision or health fact; the writer who marked the grave is living and is not named.

Judgment calls (dossier editorial resolutions)

  1. Sources. The case relies on PBS American Masters, the Zora Neale Hurston Trust (Valerie Boyd's essay and chronology), the University of Florida Smathers Libraries (which hold her papers), the Encyclopedia of Alabama, the Florida Department of State and a Library of Congress research guide. The Library of Congress collection pages, Florida Memory, the Smithsonian NMAAHC and the New York Times obituary could not be fetched (blocked or not found). Valerie Boyd's Wrapped in Rainbows is used only through her essay and chronology on the Trust's site; Robert Hemenway's biography was not read and is not cited. Wikipedia and popular sites found in searches were not used.
  2. Recent-death rule. She died in 1960, so the rule does not apply. A sick visit is included.
  3. Birth date. The true date is January 7, 1891, in Notasulga, Alabama (Trust, PBS, Encyclopedia of Alabama). From 1917 she gave her birth year as 1901 to qualify for free schooling and presented herself as at least ten years younger from then on (Trust); the 1973 headstone reads 1901 (University of Florida). The 1901 year is kept as a superseded alternative. Eatonville, Florida, which she named as her birthplace in her autobiography, is recorded in the claim's interpretation, not as an alternative date. The synthetic date of birth is 1959-01-07, a shift of 68 years.
  4. Index age and dates. The index visit on March 9, 2026 maps to March 9, 1958, when she was 67 and living in Fort Pierce, working as a substitute teacher at Lincoln Park Academy (Trust, 1958) and writing for the Fort Pierce Chronicle (1957 to 1959). The visits on March 23, April 6, May 18, June 1, September 14 and October 19, 2026 map to the same days of 1958, all before the stroke in early 1959. Her day-to-day whereabouts in 1958 are not documented in the sources read; nothing places her away from Fort Pierce then. No past medical history is documented before 1958, so that section is empty.
  5. Stroke date. The Trust gives “early 1959” and PBS 1959; the Florida Department of State gives 1960. The claim (CLM-0013) uses early 1959 with certainty “probable” and records the 1960 date as disputing. October 1959 for the welfare home is agreed.
  6. Cause of death. The Trust chronology quotes “hypertensive heart disease” and PBS agrees; the Encyclopedia of Alabama says “a heart attack.” The claim (CLM-0014) uses hypertensive heart disease with certainty “probable” and records the conflict. Her death certificate was not seen. The modern diagnosis of hypertensive heart disease with heart failure (I11.0) is linked to this claim (placement both_with_link); nothing in the record says she had heart failure in her lifetime.
  7. Name and alias. The display name Zora Neale Hurston splits simply into given and family names, so identity.name_parts is not used. The alias Zora Lee Hurston comes only from the Florida Department of State (CLM-0002, certainty “probable”); it appears in no other record. The notes call her Ms. Hurston.
  8. Living people and relatives. The writer who found and marked her grave in 1973 is living and is not named; she is called “a younger writer.” Her parents appear only in claims; her mother's death in 1904 is family history with the cause not recorded. No relative, friend or historical person is given a modern statement, decision or health fact. The friend from Eatonville who let her live rent-free appears in a claim without a name; the modern friend who lets her live without rent, her health care surrogate, the community health worker and the SHINE counselor are synthetic and unnamed.
  9. Events not used. Other events in the PBS timeline, including a false accusation that was dismissed in 1949, and the burning of her papers after her death, are not used; they do not bear on the modern episode.
  10. Presenting problems and diagnoses. Very high blood pressure at intake with morning headaches (R03.0) and breathlessness on exertion with mild ankle swelling (R06.09) are the presenting problems, resolved at the second visit, when 24-hour ambulatory monitoring confirmed stage 2 hypertension and the echocardiogram and cardiology established hypertensive heart disease with heart failure (I11.0) and HFpEF (I50.32), both recorded at the second visit. The intake documents show only what was known at intake.
  11. HFpEF decision. HFpEF is diagnosed: NT-proBNP 480 pg/mL, ejection fraction 62%, left atrial volume index 38 mL/m2, E/e' 15 and concentric hypertrophy, with an H2FPEF score of 5. The consultant considered transthyretin amyloidosis (including the hereditary form more common in Black Americans), valve disease and coronary disease and found no red flags; no technetium scan, light-chain tests or stress test were done, and the record says when they would be.
  12. Treatment choices. (1) Treatment started the morning after the 24-hour ambulatory recording, so that confirmation did not delay treatment of stage 2 blood pressure; the recording result is reported in the two-week note. (2) Chlorthalidone 12.5 mg (half of a 25 mg tablet) with amlodipine 5 mg, as the 2025 guideline advises for a Black adult without kidney disease or albuminuria (urine albumin-to-creatinine ratio 22 mg/g); no ACE inhibitor or ARB was needed. (3) Dapagliflozin for HFpEF from the consultation, through the manufacturer's patient assistance program until her drug plan with Extra Help began. (4) Spironolactone 12.5 mg added at the third visit for blood pressure above target and potassium 3.4 mmol/L. (5) Moderate-intensity atorvastatin 20 mg for primary prevention (LDL 132 to 76 mg/dL). No sacubitril-valsartan, which would have added cost without need.
  13. Coverage and costs. She has Original Medicare without drug coverage at intake (synthetic). Extra Help and the Medicare Savings Program, applied for with a SHINE counselor, are real programs; their approval within about ten weeks and the drug plan beginning the next month are synthetic simplifications, and no dollar amounts are stated. Generic medicines in 90-day fills are used throughout.
  14. Social history. Her low income is anchored to the documented $943.75 largest royalty, work as a maid, struggle to find work in the 1950s and the welfare home (CLM-0008, CLM-0009, CLM-0013). The modern food insecurity (Hunger Vital Sign, recorded as narrative), the bus, the fans without air conditioning, SNAP and energy assistance are synthetic. Her statement that she has often had to insist on being taken seriously (SOC-007) is a synthetic statement in the modern episode, written to guide respectful care, not a claim about her life. The alcohol history follows the Trust's note that she rarely drank.
  15. Stroke teaching. The stroke she had in early 1959 is the reason the modern episode teaches stroke risk and the BE FAST signs at every visit. No stroke or transient ischemic attack occurs in the modern episode.
  16. Synthetic clinical picture. Everything in the modern episode is synthetic: symptoms, every blood pressure (including the ambulatory and home averages, which are narrative), all laboratory values, the ECGs, the echocardiogram, scores (PHQ-2, KCCQ-12, Mini-Cog, AUDIT-C), the screening results at the seven-month visit (FIT, mammogram, hepatitis C, DXA and the optometry findings, all narrative), medicines and outcomes. Height (165 cm) and weights are synthetic. Reference ranges are typical adult female ranges.
  17. Sick visit. Orthostatic hypotension (I95.1) with lightheadedness in early summer heat, chosen because it follows from her medicines and her house without air conditioning and insinuates no undocumented diagnosis: an ECG to exclude arrhythmia, a normal neurological examination, creatinine 1.10 mg/dL, two days off chlorthalidone, spironolactone and dapagliflozin with fluids, a heat plan and energy assistance for cooling. It is not a historical claim.
  18. Annual wellness visit. A subsequent annual wellness visit at 67 (HCPCS G0439 and CPT 99497 in plain text); the record says her first was at the county health department clinic (synthetic). Judgment calls: RSV vaccine at 67 because heart failure raises her risk; zoster and Tdap deferred to the next visit to limit the number of injections; FIT by mail rather than colonoscopy; cervical screening not continued after 65; advance care planning with an unnamed friend as surrogate. Her wish that her papers go to a university library echoes their real fate but is a synthetic statement.
  19. Focused visits. The four chronic-care follow-ups (two weeks with the consultation, two weeks after dapagliflozin, eight weeks after spironolactone, and seven months) are documented as focused visits on the CMID hypertension and heart failure monographs, the 2025 AHA/ACC high blood pressure guideline and the 2022 AHA/ACC/HFSA heart failure guideline. One deviation is recorded instead of an invented result: the metabolic panel due one to two weeks after spironolactone was started was missed because the bus route to the laboratory changed and she had no ride; the first check came at the sick visit six weeks after the start (potassium 4.4 mmol/L), with no hyperkalemia then or at eight weeks, so no harm is evident; the corrective action was laboratory tests on visit days and rides through the county's transportation program. Synthetic findings introduced: the falling potassium on chlorthalidone, the orthostatic episode, the improvement in the KCCQ-12 from 54 to 78, and the screening results.
  20. Consultation. The cardiology referral and the consultation by Tomasz Okafor-Whitfield, MD (a fictional consultant), on the day of the two-week visit, are S. The consultant answers the five referral questions in line with what the record shows afterwards: HFpEF from hypertensive heart disease; no red flags for amyloidosis, valve disease or ischemia and no further testing now; chlorthalidone with amlodipine and a target below 130/80; dapagliflozin now through patient assistance, spironolactone if blood pressure stayed above target or potassium fell (added at the third visit), atorvastatin; and stroke risk from blood pressure and hypertrophy, with BE FAST and pulse checks rather than prolonged rhythm monitoring.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-06-01
Progress note 05 (C-CDA)
Metabolic panel (sodium, potassium, creatinine and eGFR) and magnesiumOne to two weeks after starting or changing a diuretic, SGLT2 inhibitor or MRA; then every three to six monthsThe panel due one to two weeks after spironolactone was started was missed: the bus route to the laboratory changed and she had no ride. The first check came at the sick visit six weeks after the start: potassium 4.4 mmol/L, with creatinine 1.10 mg/dL from volume depletion in the heat, not from the potassium. No harm from the missed check is evident: no hyperkalemia at six weeks or today. Corrective action: laboratory tests on clinic visit days where possible, and rides through the county's transportation program for any separate trip

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-03-23
Progress note 02 (C-CDA)
LaboratoryLipid panelOrderedLDL 132 mg/dL at intake; atorvastatin started today; panel due in four to twelve weeks
2026-09-14
Progress note 06 (C-CDA)
PreventionBreast cancer screening (mammogram)OrderedEvery two years from 40 to 74; none in many years; mammogram booked at the hospital's mobile unit, which comes to her neighborhood
2026-09-14
Progress note 06 (C-CDA)
PreventionColorectal cancer screeningOrderedAge 45 to 75; never screened; a stool immunochemical (FIT) kit given today, to return by mail, avoiding a trip and bowel preparation
2026-09-14
Progress note 06 (C-CDA)
PreventionBone density (DXA)OrderedRecommended for women 65 and older; no prior scan
2026-09-14
Progress note 06 (C-CDA)
PreventionHepatitis C screeningOrderedOne-time screening for adults 18 to 79; never tested; blood drawn today, result by telephone
2026-09-14
Progress note 06 (C-CDA)
PreventionEye examinationReferredOptometry for a dilated medical eye examination for hypertensive retinopathy, covered by Medicare Part B, with the Medicare Savings Program paying her share

Evidence to check

Retrospective claims (R)

None.

Sensitive claims

None.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-03-09NT-proBNP480 pg/mL (high)High
2026-03-09Total cholesterol212 mg/dL (high)High
2026-03-09LDL cholesterol132 mg/dL (high)High
2026-03-23Left atrial volume index38 mL/m² (high)High
2026-03-23Mitral E/e' ratio (average)15 (high)High
2026-04-06Potassium3.4 mmol/L (low)Low
2026-05-18Creatinine1.1 mg/dL (high)High
2026-05-18eGFR (CKD-EPI 2021)55 mL/min/1.73 m² (low)Low